Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonin regulates osteoclast differentiation through its transporter.

Ricardo Battaglino1, Jia Fu, Ulrike Späte

  • 1Department of Cytokine Biology, The Forsyth Institute, Boston, Massachusetts 02115, USA.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|August 18, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of Dietary Behaviors and Physical Activity with Anxiety and Depressive Symptoms among Chinese Adults Aged 18-60 Years: A Population-based Cross-sectional Study.

Biomedical and environmental sciences : BES·2026
Same author

Differential cortical responses of robot-assisted active and mirror therapy task conditions in stroke patients and healthy controls: a comparative fNIRS study.

Frontiers in neurology·2026
Same author

Tri-modal nanocatalytic microenvironment regulations for macrophage reprogramming and osteoporotic fracture healing promotion.

Materials today. Bio·2026
Same author

YTHDF1 promotes myelin phagocytosis through m6A-dependent regulation of Galectin-3 to enhance macrophage glycolysis in painful diabetic neuropathy.

International immunopharmacology·2026
Same author

Clinicopathologic characteristics of uterine malignant epithelioid neoplasms with EWSR1::CREM fusion: Report of 2 cases at a novel site with literature review.

Virchows Archiv : an international journal of pathology·2026
Same author

Multi-Omics Analysis of <i>Bombyx batryticatus</i> Formation Reveals Strain-Dependent Host Molecular Responses and Biomass Variation.

Journal of fungi (Basel, Switzerland)·2026

The serotonin system influences bone health by affecting osteoclast differentiation. Antidepressants targeting serotonin transporter (5-HTT) may impact bone mass, suggesting a link between mood regulation and skeletal integrity.

Area of Science:

  • Bone Biology and Serotonergic System Interactions
  • Molecular Mechanisms of Osteoclastogenesis
  • Pharmacological Effects on Bone Metabolism

Background:

  • Clinical observations suggest links between the serotonergic and skeletal systems, but underlying mechanisms remain unclear.
  • The serotonin transporter (5-HTT) is crucial for serotonin clearance in neural synapses.
  • Osteoclasts play a key role in bone resorption and are central to bone homeostasis.

Purpose of the Study:

  • To investigate the role of the serotonin system, specifically the serotonin transporter (5-HTT), in osteoclast differentiation and function.
  • To determine the effects of fluoxetine and reserpine on osteoclastogenesis.
  • To explore the potential impact of antidepressants on bone mass.

Main Methods:

Related Experiment Videos

  • Gene microarrays identified 5-HTT expression in RANKL-induced osteoclasts.
  • Osteoclast differentiation was modeled using RAW264.7 cells and mouse bone marrow cells stimulated with RANKL.
  • The effects of 5-HTT inhibition (fluoxetine) and 5-HT transport inhibition (reserpine) on osteoclast differentiation and activation were assessed.

    • Main Results:

    • Osteoclasts express functional 5-HTT, which is inhibited by fluoxetine.
    • Fluoxetine reduced osteoclast differentiation by affecting NF-kappa B activation and I kappa B alpha levels.
    • 5-HT enhanced differentiation, while reserpine potentiated RANKL-induced osteoclast formation, highlighting the role of intracellular 5-HT.

    Conclusions:

    • The serotonin system, particularly 5-HTT, is involved in regulating osteoclast differentiation.
    • Commonly used antidepressant medications targeting 5-HTT may influence bone mass.
    • These findings suggest a novel mechanism linking mood regulation and skeletal health.